Sharing our paper in @natureportfolio.nature.com bit.ly/49gaDsq We report a novel framework for off-the-shelf T cell therapy development, manufacturing, and clinical risk reduction.
@qimrb.bsky.social @parkerici.bsky.social @sitcancer.bsky.social #immunotherapy #CellTherapy #AdoptiveTCellTherapy
@qimrb.bsky.social @parkerici.bsky.social @sitcancer.bsky.social #immunotherapy #CellTherapy #AdoptiveTCellTherapy
January 12, 2026 at 10:08 AM
Sharing our paper in @natureportfolio.nature.com bit.ly/49gaDsq We report a novel framework for off-the-shelf T cell therapy development, manufacturing, and clinical risk reduction.
@qimrb.bsky.social @parkerici.bsky.social @sitcancer.bsky.social #immunotherapy #CellTherapy #AdoptiveTCellTherapy
@qimrb.bsky.social @parkerici.bsky.social @sitcancer.bsky.social #immunotherapy #CellTherapy #AdoptiveTCellTherapy
Terrific #ImmunoEngineering #AdoptiveTcellTherapy #Tcells Update from @vicalbarran.bsky.social et al at @nature.com communications | OPEN ACCESS | Online Now | #CARTcells | #TILs | #TCR | #immunotherapy | #immunoncology |
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Unlocking the potential of engineered immune cell therapy for solid tumors - Nature Communications
Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellula...
www.nature.com
January 30, 2025 at 3:59 PM
Terrific #ImmunoEngineering #AdoptiveTcellTherapy #Tcells Update from @vicalbarran.bsky.social et al at @nature.com communications | OPEN ACCESS | Online Now | #CARTcells | #TILs | #TCR | #immunotherapy | #immunoncology |
www.nature.com/articles/s41...
www.nature.com/articles/s41...